Literature DB >> 11950440

Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors.

Ioannis Iakovou1, George Dangas, Roxana Mehran, Alexandra J Lansky, Yoshio Kobayashi, Milena Adamian, Sotir Polena, Micheal B Collins, Gary S Roubin, Gregg W Stone, Martin B Leon, Jeffrey W Moses.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11950440     DOI： 10.1016/s0002-9149(02)02251-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

Review 1.  Patient-specific antiplatelet therapy.

Authors:  Ian D Conde; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300

Review 2.  Acute coronary syndromes: should women receive less antithrombotic medication than men?

Authors:  N Danchin
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

3.  Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.

Authors:  Michelle L O'Donoghue; Deepak L Bhatt; Gregg W Stone; Ph Gabriel Steg; C Michael Gibson; Christian W Hamm; Matthew J Price; Jayne Prats; Tiepu Liu; Efthymios N Deliargyris; Kenneth W Mahaffey; Harvey D White; Robert A Harrington
Journal:  Circulation       Date:  2016-01-19       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.